Literature DB >> 17519413

Burden, features, and outcome of neurological involvement in acute falciparum malaria in Kenyan children.

Richard Idro1, Moses Ndiritu, Bernhards Ogutu, Sadik Mithwani, Kathryn Maitland, James Berkley, Jane Crawley, Gregory Fegan, Evasius Bauni, Norbert Peshu, Kevin Marsh, Brian Neville, Charles Newton.   

Abstract

CONTEXT: Plasmodium falciparum appears to have a particular propensity to involve the brain but the burden, risk factors, and full extent of neurological involvement have not been systematically described.
OBJECTIVES: To determine the incidence and describe the clinical phenotypes and outcomes of neurological involvement in African children with acute falciparum malaria. DESIGN, SETTING, AND PATIENTS: A review of records of all children younger than 14 years admitted to a Kenyan district hospital with malaria from January 1992 through December 2004. Neurological involvement was defined as convulsive seizures, agitation, prostration, or impaired consciousness or coma. MAIN OUTCOME MEASURES: The incidence, pattern, and outcome of neurological involvement.
RESULTS: Of 58,239 children admitted, 19,560 (33.6%) had malaria as the primary clinical diagnosis. Neurological involvement was observed in 9313 children (47.6%) and manifested as seizures (6563/17,517 [37.5%]), agitation (316/11,193 [2.8%]), prostration (3223/15,643 [20.6%]), and impaired consciousness or coma (2129/16,080 [13.2%]). In children younger than 5 years, the mean annual incidence of admissions with malaria was 2694 per 100,000 persons and the incidence of malaria with neurological involvement was 1156 per 100,000 persons. However, readmissions may have led to a 10% overestimate in incidence. Children with neurological involvement were older (median, 26 [interquartile range {IQR}, 15-41] vs 21 [IQR, 10-40] months; P<.001), had a shorter duration of illness (median, 2 [IQR, 1-3] vs 3 [IQR, 2-3] days; P<.001), and a higher geometric mean parasite density (42.0 [95% confidence interval {CI}, 40.0-44.1] vs 30.4 [95% CI, 29.0-31.8] x 10(3)/microL; P<.001). Factors independently associated with neurological involvement included past history of seizures (adjusted odds ratio [AOR], 3.50; 95% CI, 2.78-4.42), fever lasting 2 days or less (AOR, 2.02; 95% CI, 1.64-2.49), delayed capillary refill time (AOR, 3.66; 95% CI, 2.40-5.56), metabolic acidosis (AOR, 1.55; 95% CI, 1.29-1.87), and hypoglycemia (AOR, 2.11; 95% CI, 1.31-3.37). Mortality was higher in patients with neurological involvement (4.4% [95% CI, 4.2%-5.1%] vs 1.3% [95% CI, 1.1%-1.5%]; P<.001). At discharge, 159 (2.2%) of 7281 patients had neurological deficits.
CONCLUSIONS: Neurological involvement is common in children in Kenya with acute falciparum malaria, and is associated with metabolic derangements, impaired perfusion, parasitemia, and increased mortality and neurological sequelae. This study suggests that falciparum malaria exposes many African children to brain insults.

Entities:  

Mesh:

Year:  2007        PMID: 17519413      PMCID: PMC2676709          DOI: 10.1001/jama.297.20.2232

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  32 in total

Review 1.  Severe falciparum malaria. World Health Organization, Communicable Diseases Cluster.

Authors: 
Journal:  Trans R Soc Trop Med Hyg       Date:  2000-04       Impact factor: 2.184

2.  Severe malaria in children in areas with low, moderate and high transmission intensity in Uganda.

Authors:  R Idro; J Aloyo; L Mayende; E Bitarakwate; C C John; G W Kivumbi
Journal:  Trop Med Int Health       Date:  2006-01       Impact factor: 2.622

Review 3.  Cerebral malaria.

Authors:  G Turner
Journal:  Brain Pathol       Date:  1997-01       Impact factor: 6.508

4.  The cost of treating paediatric malaria admissions and the potential impact of insecticide-treated mosquito nets on hospital expenditure.

Authors:  J M Kirigia; R W Snow; J Fox-Rushby; A Mills
Journal:  Trop Med Int Health       Date:  1998-02       Impact factor: 2.622

5.  The global distribution of clinical episodes of Plasmodium falciparum malaria.

Authors:  Robert W Snow; Carlos A Guerra; Abdisalan M Noor; Hla Y Myint; Simon I Hay
Journal:  Nature       Date:  2005-03-10       Impact factor: 49.962

6.  Increased prevalence of epilepsy associated with severe falciparum malaria in children.

Authors:  Julie A Carter; Brian G R Neville; Steven White; Amanda J Ross; Godfrey Otieno; Neema Mturi; Cris Musumba; Charles R J C Newton
Journal:  Epilepsia       Date:  2004-08       Impact factor: 5.864

7.  Spatial and temporal heterogeneity of Anopheles mosquitoes and Plasmodium falciparum transmission along the Kenyan coast.

Authors:  Charles M Mbogo; Joseph M Mwangangi; Joseph Nzovu; Weidong Gu; Guiyan Yan; James T Gunter; Chris Swalm; Joseph Keating; James L Regens; Josephat I Shililu; John I Githure; John C Beier
Journal:  Am J Trop Med Hyg       Date:  2003-06       Impact factor: 2.345

8.  Convulsions in childhood malaria.

Authors:  Y Wattanagoon; S Srivilairit; S Looareesuwan; N J White
Journal:  Trans R Soc Trop Med Hyg       Date:  1994 Jul-Aug       Impact factor: 2.184

9.  Clinical features and prognostic indicators in paediatric cerebral malaria: a study of 131 comatose Malawian children.

Authors:  M E Molyneux; T E Taylor; J J Wirima; A Borgstein
Journal:  Q J Med       Date:  1989-05

10.  Convulsions with malaria: febrile or indicative of cerebral involvement?

Authors:  G O Akpede; R M Sykes; P O Abiodun
Journal:  J Trop Pediatr       Date:  1993-12       Impact factor: 1.165

View more
  63 in total

1.  Cognitive Outcomes and Psychiatric Symptoms of Retinopathy-Positive Cerebral Malaria: Cohort Description and Baseline Results.

Authors:  Rachel Brim; Sebastian Mboma; Margaret Semrud-Clikeman; Sam Kampondeni; Jed Magen; Terrie Taylor; John Langfitt
Journal:  Am J Trop Med Hyg       Date:  2017-07       Impact factor: 2.345

Review 2.  Diagnosis and management of the neurological complications of falciparum malaria.

Authors:  Saroj K Mishra; Charles R J C Newton
Journal:  Nat Rev Neurol       Date:  2009-04       Impact factor: 42.937

3.  Child neurology services in Africa.

Authors:  Jo M Wilmshurst; Eben Badoe; Robinson D Wammanda; Macpherson Mallewa; Angelina Kakooza-Mwesige; Andre Venter; Charles R Newton
Journal:  J Child Neurol       Date:  2011-10-21       Impact factor: 1.987

Review 4.  Microbes' roadmap to neurons.

Authors:  Krister Kristensson
Journal:  Nat Rev Neurosci       Date:  2011-05-18       Impact factor: 34.870

5.  Expression microarray analysis implicates apoptosis and interferon-responsive mechanisms in susceptibility to experimental cerebral malaria.

Authors:  Fiona E Lovegrove; Sina A Gharib; Samir N Patel; Cheryl A Hawkes; Kevin C Kain; W Conrad Liles
Journal:  Am J Pathol       Date:  2007-11-08       Impact factor: 4.307

6.  Severe neurological sequelae and behaviour problems after cerebral malaria in Ugandan children.

Authors:  Richard Idro; Angelina Kakooza-Mwesige; Stephen Balyejjussa; Grace Mirembe; Christine Mugasha; Joshua Tugumisirize; Justus Byarugaba
Journal:  BMC Res Notes       Date:  2010-04-16

7.  Platelet factor 4 regulation of monocyte KLF4 in experimental cerebral malaria.

Authors:  Kalyan Srivastava; David J Field; Angela Aggrey; Munekazu Yamakuchi; Craig N Morrell
Journal:  PLoS One       Date:  2010-05-03       Impact factor: 3.240

8.  Severe atovaquone-resistant Plasmodium falciparum malaria in a Canadian traveller returned from the Indian subcontinent.

Authors:  Thomas L Perry; Prativa Pandey; Jennifer M Grant; Kevin C Kain
Journal:  Open Med       Date:  2009-01-20

9.  Safety of epoietin beta-quinine drug combination in children with cerebral malaria in Mali.

Authors:  Stéphane Picot; Anne-Lise Bienvenu; Salimata Konate; Sibiri Sissoko; Abdoulaye Barry; Elisabeth Diarra; Karidiatou Bamba; Abdoulaye Djimdé; Ogobara K Doumbo
Journal:  Malar J       Date:  2009-07-24       Impact factor: 2.979

10.  Malaria paediatric hospitalization between 1999 and 2008 across Kenya.

Authors:  Emelda A Okiro; Victor A Alegana; Abdisalan M Noor; Juliette J Mutheu; Elizabeth Juma; Robert W Snow
Journal:  BMC Med       Date:  2009-12-09       Impact factor: 8.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.